A Phase 2, Double-Masked, Placebo-Controlled, Dose Range Finding Study of Danicopan (ALXN2040) in Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Clinical Trial Grant
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
Alexion Pharmaceuticals, Inc.
Start Date
July 6, 2022
End Date
June 30, 2027
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
Alexion Pharmaceuticals, Inc.
Start Date
July 6, 2022
End Date
June 30, 2027